Epigral [EPIGRAL] vs Tata Chemicals [TATACHEM] Detailed Stock Comparison
Epigral
NSE
Loading...
Tata Chemicals
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Epigral wins in 13 metrics, Tata Chemicals wins in 7 metrics, with 0 ties. Epigral appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Epigral | Tata Chemicals | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 17.39 | 74.62 | Epigral |
| Price-to-Book Ratio | 3.99 | 1.10 | Tata Chemicals |
| Debt-to-Equity Ratio | 31.11 | 31.43 | Epigral |
| PEG Ratio | 0.22 | 1.10 | Epigral |
| EV/EBITDA | 11.77 | 15.66 | Epigral |
| Profit Margin (TTM) | 17.26% | 2.27% | Epigral |
| Operating Margin (TTM) | 20.09% | 9.92% | Epigral |
| EBITDA Margin (TTM) | 20.09% | 9.92% | Epigral |
| Return on Equity | 18.78% | 2.17% | Epigral |
| Return on Assets (TTM) | 11.35% | 0.62% | Epigral |
| Free Cash Flow (TTM) | $2.46B | $-2.44B | Epigral |
| Dividend Yield | 0.64% | 1.19% | Tata Chemicals |
| 1-Year Return | -13.86% | -10.48% | Tata Chemicals |
| Price-to-Sales Ratio (TTM) | 3.03 | 1.61 | Tata Chemicals |
| Enterprise Value | $80.93B | $303.63B | Tata Chemicals |
| EV/Revenue Ratio | 3.23 | 2.05 | Tata Chemicals |
| Gross Profit Margin (TTM) | 47.40% | 68.11% | Tata Chemicals |
| Revenue per Share (TTM) | $588 | $582 | Epigral |
| Earnings per Share (Diluted) | $101.24 | $12.51 | Epigral |
| Beta (Stock Volatility) | -0.15 | 0.48 | Epigral |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Epigral vs Tata Chemicals Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Epigral | 0.96% | -2.46% | -3.72% | -3.95% | -0.63% | -5.89% |
| Tata Chemicals | 0.24% | 0.40% | -0.29% | -1.75% | 15.90% | -9.13% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Epigral | -13.86% | 75.70% | 75.70% | 75.70% | 75.70% | 75.70% |
| Tata Chemicals | -10.48% | -14.69% | 224.94% | 138.12% | 128.68% | 358.14% |
News Based Sentiment: Epigral vs Tata Chemicals
Epigral
News based Sentiment: MIXED
Epigral delivered exceptional Q1 FY26 results, showcasing strong revenue and profit growth, but the resignation of the CFO introduces uncertainty. While the company's strategic shift and financial health are positive, the leadership change and recent share price decline create a mixed investment picture.
Tata Chemicals
News based Sentiment: MIXED
Tata Chemicals delivered strong profit growth in Q1 FY26, but revenue faced headwinds. Analyst views are mixed, with some upgrades and a high P/E ratio creating a complex picture. The focus on sustainability adds a positive dimension, but overall, the month presents a mixed investment story.
Performance & Financial Health Analysis: Epigral vs Tata Chemicals
| Metric | EPIGRAL | TATACHEM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹76.01B | ₹239.86B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 27,338 | 342,309 |
| 90 Day Avg. Volume | 81,947 | 808,956 |
| Last Close | ₹1,780.80 | ₹945.55 |
| 52 Week Range | ₹1,502.35 - ₹2,406.75 | ₹756.00 - ₹1,247.35 |
| % from 52W High | -26.01% | -24.20% |
| All-Time High | ₹2,406.75 (Sep 30, 2024) | ₹1,349.00 (Mar 04, 2024) |
| % from All-Time High | -26.01% | -29.91% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.07% | -0.02% |
| Quarterly Earnings Growth | 0.87% | 0.68% |
| Financial Health | ||
| Profit Margin (TTM) | 0.17% | 0.02% |
| Operating Margin (TTM) | 0.20% | 0.10% |
| Return on Equity (TTM) | 0.19% | 0.02% |
| Debt to Equity (MRQ) | 31.11 | 31.43 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹441.46 | ₹847.63 |
| Cash per Share (MRQ) | ₹22.08 | ₹54.98 |
| Operating Cash Flow (TTM) | ₹4.17B | ₹11.31B |
| Levered Free Cash Flow (TTM) | ₹3.58B | ₹2.35B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.64% | 1.19% |
| Last 12-Month Dividend | ₹11.00 | ₹11.00 |
Valuation & Enterprise Metrics Analysis: Epigral vs Tata Chemicals
| Metric | EPIGRAL | TATACHEM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 17.39 | 74.62 |
| Forward P/E | 18.26 | 18.92 |
| PEG Ratio | 0.22 | 1.10 |
| Price to Sales (TTM) | 3.03 | 1.61 |
| Price to Book (MRQ) | 3.99 | 1.10 |
| Market Capitalization | ||
| Market Capitalization | ₹76.01B | ₹239.86B |
| Enterprise Value | ₹80.93B | ₹303.63B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.23 | 2.05 |
| Enterprise to EBITDA | 11.77 | 15.66 |
| Risk & Other Metrics | ||
| Beta | -0.15 | 0.48 |
| Book Value per Share (MRQ) | ₹441.46 | ₹847.63 |
Financial Statements Comparison: Epigral vs Tata Chemicals
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EPIGRAL | TATACHEM |
|---|---|---|
| Revenue/Sales | ₹6.07B | ₹37.19B |
| Cost of Goods Sold | ₹3.19B | ₹11.86B |
| Gross Profit | ₹2.87B | ₹25.33B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹1.22B | ₹3.69B |
| EBITDA | ₹1.72B | ₹7.87B |
| Pre-Tax Income | ₹1.07B | ₹3.60B |
| Income Tax | ₹-536.80M | ₹440.00M |
| Net Income (Profit) | ₹1.61B | ₹3.16B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EPIGRAL | TATACHEM |
|---|---|---|
| Cash & Equivalents | ₹186.40M | ₹5.48B |
| Total Current Assets | ₹7.75B | ₹67.20B |
| Total Current Liabilities | ₹4.93B | ₹61.39B |
| Long-Term Debt | ₹4.52B | ₹48.16B |
| Total Shareholders Equity | ₹19.05B | ₹225.01B |
| Retained Earnings | ₹17.85B | ₹92.79B |
| Property, Plant & Equipment | ₹22.19B | ₹4.31B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EPIGRAL | TATACHEM |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | EPIGRAL | TATACHEM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 27,338 | 342,309 |
| Average Daily Volume (90 Day) | 81,947 | 808,956 |
| Shares Outstanding | 43.14M | 254.76M |
| Float Shares | 13.34M | 156.06M |
| % Held by Insiders | 0.69% | 0.39% |
| % Held by Institutions | 0.05% | 0.30% |
Dividend Analysis & Yield Comparison: Epigral vs Tata Chemicals
| Metric | EPIGRAL | TATACHEM |
|---|---|---|
| Last 12-Month Dividend | ₹11.00 | ₹11.00 |
| Last 12-Month Dividend Yield | 0.64% | 1.19% |
| 3-Year Avg Annual Dividend | ₹3.67 | ₹14.50 |
| 3-Year Avg Dividend Yield | 0.22% | 1.45% |
| 3-Year Total Dividends | ₹11.00 | ₹43.50 |
| Ex-Dividend Date | Jun 20, 2025 | Jun 12, 2025 |